Cepheid

Cepheid is a molecular diagnostics company specializing in the development, manufacturing, and commercialization of fully integrated systems for testing in clinical and non-clinical settings. They generate revenue through the sale of diagnostic tests and instruments, particularly their GeneXpert system, which offers rapid, accurate molecular testing for infectious diseases, genetic disorders, and cancer. Founded in 1996, Cepheid has been a pioneer in the field of molecular diagnostics, and their technology played a crucial role in the rapid testing for COVID-19 during the pandemic.

Recent Posts by Cepheid

1-20 of 155